Drug profile · INN
mesalazine
ASACOL
mesalazine (ASACOL) is a arachidonate 5-lipoxygenase inhibitor. Associated with Ferring Pharmaceuticals.
TGA: approved PMDA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 15
News articles 0
Drug details — mesalazine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 15
- Data quality
- 0.81
Quick answer
mesalazine (ASACOL) is a arachidonate 5-lipoxygenase inhibitor. Associated with Ferring Pharmaceuticals.
Key facts
INN mesalazine
Brand ASACOL
Mechanism Arachidonate 5-lipoxygenase inhibitor
Target Polyunsaturated fatty acid 5-lipoxygenase
Originator Ferring Pharmaceuticals
Mechanism of action
Arachidonate 5-lipoxygenase inhibitor
Primary target: Polyunsaturated fatty acid 5-lipoxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| PMDA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is mesalazine?
mesalazine (ASACOL) is a arachidonate 5-lipoxygenase inhibitor. Associated with Ferring Pharmaceuticals.
What is the brand name for mesalazine?
ASACOL is a marketed brand name for mesalazine. Check FDA Drugs@FDA for the current US label holder and prescribing information.